我們已在上線！ 進一步了解
PILL圖示

Direxion Daily Pharmaceutical & Medical Bull 3X ETF
PILL

13.41 USD
-0.91
6.35%
收盤時 已更新 10月16日 下午4:00 EDT
盤前交易
盤後交易
13.20
-0.21
1.57%
1天
-6.35%
5天
-12.41%
1個月
-23.06%
3個月
-27.28%
6個月
9.2%
今年迄今
14.03%
1年
66.17%
5年
-23.42%
10年
-42.69%
醫療保健

新聞

正面
中性
負面
市場情緒 3個月
正面 0%
中性 0%
負面 0%
中性
ETF Trends
4 個月前
Top Performing Leveraged/Inverse ETFs: 06/14/2026
Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
Top Performing Leveraged/Inverse ETFs: 06/14/2026
中性
Seeking Alpha
5 個月前
Medical Technology Stocks: Innovation Endures As Valuations Reset
Investors are questioning the staying power of medical technology (medtech) stocks, which have fallen from grace since the COVID-19 pandemic. The starting point is to distinguish between medtech and other healthcare industries.
Medical Technology Stocks: Innovation Endures As Valuations Reset
中性
Seeking Alpha
6 個月前
Trump's 100% Pharma Tariffs Will Have A Limited Effect On The Sector
On Thursday, news broke that the US will likely start levying a 100% tariff on branded pharmaceutical imports. The specifics remain unclear, but the levy is expected to be relatively narrow in scope, since many exemptions have already been negotiated.
Trump's 100% Pharma Tariffs Will Have A Limited Effect On The Sector
負面
Seeking Alpha
7 個月前
Europe's Last Chance To Revive Its Pharmaceutical Innovation Power
Europe's pharmaceutical industry needs to make sure it doesn't become yesterday's news. Its biopharmaceutical innovation capacity has been gradually declining for decades, and the rapid ascent of China and President Trump's policies risk accelerating that decay.
Europe's Last Chance To Revive Its Pharmaceutical Innovation Power
中性
ETF Trends
10 個月前
Top Performing Leveraged/Inverse ETFs: 12/14/2025
Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
Top Performing Leveraged/Inverse ETFs: 12/14/2025
中性
ETF Trends
11 個月前
Top Performing Leveraged/Inverse ETFs: 11/16/2025
Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
Top Performing Leveraged/Inverse ETFs: 11/16/2025
正面
Seeking Alpha
11 個月前
Investing In Health Stocks - How Policy Clarity Is Opening Doors
The healthcare sector has experienced one of its most significant de-ratings in 35 years, with valuations now at a 30% discount to the broader market. Healthcare trades at historical valuation discounts across multiple metrics.
Investing In Health Stocks - How Policy Clarity Is Opening Doors
正面
ETF Trends
去年
As M&A Deals Rise, Can Biotech Pharma Break Loose?
After a relatively sluggish 2024 for mergers & acquisitions (M&A) activity in the biopharma sector, the environment could be more conducive for deals in the rest of 2025. The industry, like the rest of the capital markets, will be keeping an eye on interest rates as monetary easing by the U.S.
As M&A Deals Rise, Can Biotech Pharma Break Loose?
中性
ETF Trends
去年
Top Performing Leveraged/Inverse ETFs: 08/17/2025
Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
Top Performing Leveraged/Inverse ETFs: 08/17/2025
中性
Seeking Alpha
去年
Healthcare Sector Checkup As U.S. Looks To Change Regulations
Outlook for pharma sector as Trump pushes for regulatory changes. The impact of tariffs on drugmakers.
Healthcare Sector Checkup As U.S. Looks To Change Regulations
查看新聞排名
價格圖表採用Lightweight Charts™實作